Pharmaceutical Distribution Industry 2020

Language:
Japanese
Product Code No:
C62108400
Issued In:
2020/08
#of Pages:
221
Publication Cycle:
Biannual
Format:
PDF

Price

150,000 yen ($1,444.67)
(excluding consumption tax)
300,000 yen ($2,889.34)
(excluding consumption tax)
450,000 yen ($4,334.01)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 103.83 yen , 2020/11/23 Japan)

Coverage: (Product/service)

Pharmaceutical distribution Industry, Drug wholesaling Industry

Research Target:

Pharmaceutical distributors, drug wholesalers, etc.

Research Content:

I   Medical Care and Society to Go Along With COVID-19

  1. Medical Care and Society Being Confused by Expansion of COVID-19 Infections
  • Expanded infections within a short period of time
  • Issues that have become clear from COVID-19 pandemics
  • Countries do not know what have been effective to cure the disease
  • Patients at medical institutions and pharmacies significantly decreased, which significantly deteriorated the management conditions of hospitals and other medical institutions
  • Japan has been revealed to be vulnerable in stopping expansion of infections
  • Infectious Disease Law became the bottleneck to delay the strengthening of PCR testing structure
  • Reassessment of supply chains dependent on China
  • Business management issues that have been revealed by COVID-19 pandemics
  • "New Normal" in the era to go along with COVID-19
  • DX in progress in the Japanese companies
  1. Report on Revision of the Medical Payment System for FY2020
  2. Consumption Tax Hike to 10% Has Achieved Finally
  3. Current Status and Future Forecast regarding Online Medical Care
  4. Opinions Not to Revise NHI Price during In-Between Year Have Strengthened

II   Medical Care under New Normal

  • Medical institutions have become cornered by COVID-19 infections
  • How hospitals and clinics should be in the "With Corona" era
  • Pharmacies and pharmacists were low profile in the COVID-19 infected society
  • How pharmacies should be in the "With Corona" era
  • Digitization has been accelerated in pharmaceutical companies triggered by COVID-19 infections
  • How pharmaceutical companies should be in the "With Corona" era

III   Drug Wholesalers Able to Survive in "New Normal"

  • Pharmaceutical distribution market became confused in the unpredictable situation
  • Can the market adapt to "New Normal?"
  • The most feasible drug wholesaler that can adapt to the changes
  • How drug wholesalers should be in the "With Corona" era

Price

written in Japanese
150,000 yen ($1,444.67)
(excluding consumption tax)
300,000 yen ($2,889.34)
(excluding consumption tax)
450,000 yen ($4,334.01)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 103.83 yen , 2020/11/23 Japan)